[1]
|
李霖, 李茂岚, 刘颖斌. 胆囊癌综合治疗的进展和展望[J]. 肝胆外科杂志, 2020, 28(6): 414-417.
|
[2]
|
付佳禄, 李起, 张东, 耿智敏. 《胆囊癌诊断和治疗指南》(2019版)更新解读[J]. 肝胆胰外科杂志, 2020, 32(11): 659-663+666.
|
[3]
|
Bal, M.M., Ramadwar, M., Deodhar, K. and Shrikhande, S. (2015) Pathology of Gallbladder Car-cinoma: Current Understanding and New Perspectives. Pathology & Oncology Research, 21, 509-525.
https://doi.org/10.1007/s12253-014-9886-3
|
[4]
|
Alkhayyat, M., Abou Saleh, M., Qapaja, T., Abureesh, M., Al-momani, A., Mansoor, E. and Chahal, P. (2021) Epidemiology of Gallbladder Cancer in the Unites States: A Popula-tion-Based Study. Chinese Clinical Oncology, 10, 25.
https://doi.org/10.21037/cco-20-230
|
[5]
|
Rawla, P., Sunkara, T., Thandra, K.C. and Barsouk, A. (2019) Epidemi-ology of Gallbladder Cancer. Clinical and Experimental Hepatology, 5, 93-102. https://doi.org/10.5114/ceh.2019.85166
|
[6]
|
宋彦伟, 程军, 罗威, 蒋丽萍. 胆囊息肉样病变直径对判断息肉性质的价值分析[J]. 实用肝脏病杂志, 2020, 23(1): 130-133.
|
[7]
|
Sharma, A., Sharma, K.L., Gupta, A., Yadav, A. and Kumar, A. (2017) Gallbladder Cancer Epidemiology, Pathogenesis and Molecular Genetics: Recent Update. World Journal of Gastroenterology, 23, 3978-3998.
https://doi.org/10.3748/wjg.v23.i22.3978
|
[8]
|
余波锋, 田广磊, 陈伦牮. 胆囊癌的发病因素、分子机制及手术方式的研究进展[J]. 现代医学, 2022, 50(6): 793-797.
|
[9]
|
刘立业, 仝林虎. 胆囊癌诊断的研究进展[J]. 内蒙古医学杂志, 2017, 49(6): 675-679.
https://doi.org/10.16096/J.cnki.nmgyxzz.2017.49.06.012
|
[10]
|
张剑, 邓卓凡, 龚建平. 胆囊癌发病相关危险因素的研究进展[J]. 现代医药卫生, 2022, 38(1): 85-89.
|
[11]
|
Schmidt, M.A., Marcano-Bonilla, L. and Roberts, L.R. (2019) Gallbladder Cancer: Epidemiology and Genetic Risk Associations. Chinese Clinical Oncology, 8, 31. https://doi.org/10.21037/cco.2019.08.13
|
[12]
|
Goetze, T.O. (2015) Gallbladder Carcinoma: Prognostic Factors and Therapeutic Options. World Journal of Gastroenterology, 21, 12211-12217. https://doi.org/10.3748/wjg.v21.i43.12211
|
[13]
|
Li, Z.M., Wu, Z.X., Han, B., et al. (2016) The Association between BMI and Gallbladder Cancer Risk: A Meta-Analysis. Oncotarget, 7, 43669-43679. https://doi.org/10.18632/oncotarget.9664
|
[14]
|
Abou-Alfa, G.K., Jarnagin, W., Lowery, M., et al. (2014) Liver and Bile Duct Cancer. In: Niederhuber, J.E., Armitage, J.O. and Doroshow, J.H., et al., Eds., Abeloff’s Clinical Oncology, 5th Edition, Sanders, Philadelphia, 1373-1396.
https://doi.org/10.1016/B978-1-4557-2865-7.00080-1
|
[15]
|
Dwivedi, A.N., Jain, S. and Dixit, R. (2015) Gall Bladder Carcinoma: Aggressive Malignancy with Protean Loco-Regional and Distant Spread. World Journal of Clinical Cases, 3, 231-244. https://doi.org/10.12998/wjcc.v3.i3.231
|
[16]
|
海琳琳. 超声诊断原发性胆囊癌易临床误诊的原因分析[J]. 黑龙江医药, 2019, 32(1): 194-196.
https://doi.org/10.14035/j.cnki.hljyy.2019.01.094
|
[17]
|
Hennedige, T.P., Neo, W.T. and Venkatesh, S.K. (2014) Imaging of Malignancies of the Biliary Tract—An Update. Cancer Imaging, 14, 14.
|
[18]
|
陈宇. 超声造影在胆囊癌诊断中的应用价值[J]. 影像研究与医学应用, 2017, 1(7): 39-40.
|
[19]
|
于志远, 孙岩. 胆囊癌的诊断与治疗进展[J]. 中国普外基础与临床杂志, 2019, 26(3): 282-287.
|
[20]
|
Tanaka, K., Katanuma, A., Hayashi, T., Kin, T. and Takahashi, K. (2021) Role of Endoscopic Ultrasound for Gallbladder Disease. Journal of Medical Ultrasonics, 48, 187-198. https://doi.org/10.1007/s10396-020-01030-w
|
[21]
|
帕成周, 邬善敏. 胆囊癌诊断治疗研究新进展[J]. 疑难病杂志, 2019, 18(7): 748-751+756.
|
[22]
|
晏争研. 多层螺旋CT检查在诊断胆囊癌中的临床价值[J]. 当代医药论丛, 2016, 14(16): 108-109.
|
[23]
|
姚兴朝, 谢楠, 梁正荣, 周涛平, 晏明鹏, 付必莽. CT和MRI诊断早期胆囊癌的对比分析[J]. 河南科技大学学报(医学版), 2016, 34(1): 35-37. https://doi.org/10.15926/j.cnki.issn1672-688x.2016.01.012
|
[24]
|
Granata, V., Fusco, R., Catalano, O., Filice, S., Avallone, A., Piccirillo, M., Leongito, M., Palaia, R., Grassi, R., Izzo, F. and Petrillo, A. (2017) Uncommon Neoplasms of the Biliary Tract: Radiological Findings. The British Journal of Radiology, 90, Article ID: 20160561. https://doi.org/10.1259/bjr.20160561
|
[25]
|
吴月圆. 探讨多排螺旋CT及MRI在胆囊癌临床诊断及鉴别诊断中的应用价值[J]. 医学食疗与健康, 2021, 19(5): 140-141.
|
[26]
|
Florescu, L.M., Florescu, D.N. and Gheonea, I.A. (2017) The Importance of Imaging Techniques in the Assessment of Biliary Tract Cancer. Current Health Sciences Journal, 43, 201-208.
|
[27]
|
张鹤, 乔英博. 原发性胆囊癌的MRI、MRCP诊断价值分析[J]. 中国医药指南, 2017, 15(27): 115-116.
https://doi.org/10.15912/j.cnki.gocm.2017.27.095
|
[28]
|
Annunziata, S., Pizzuto, D.A., Caldarella, C., Galiandro, F., Sadeghi, R. and Treglia, G. (2015) Diagnostic Accuracy of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomog-raphy in Gallbladder Cancer: A Meta-Analysis. World Journal of Gastroenterology, 21, 11481-11488. https://doi.org/10.3748/wjg.v21.i40.11481
|
[29]
|
Ramos-Font, C., Gómez-Rio, M., Rodríguez-Fernández, A., Jimé-nez-Heffernan, A., Sánchez, R.S. and Llamas-Elvira, J.M. (2014) Ability of FDG-PET/CT in the Detection of Gallblad-der Cancer. Journal of Surgical Oncology, 109, 218-224. https://doi.org/10.1002/jso.23476
|
[30]
|
Leung, U., Pan-dit-Taskar, N., Corvera, C.U., D’Angelica, M.I., Allen, P.J., Kingham, T.P., DeMatteo, R.P., Jarnagin, W.R. and Fong, Y. (2014) Impact of Pre-Operative Positron Emission Tomography in Gallbladder Cancer. HPB (Oxford), 16, 1023-1030. https://doi.org/10.1111/hpb.12282
|
[31]
|
张阳, 杨清堂. 血清CA125、CA199与CEA联合检测对胆囊癌的诊断价值分析[J]. 现代消化及介入诊疗, 2019, 24(12): 1465-1467.
|
[32]
|
Kang, J.S., Hong, S.Y., Han, Y., Sohn, H.J., Lee, M., Kang, Y.H., Kim, H.S., Kim, H., Kwon, W. and Jang, J.Y. (2021) Limits of Serum Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 as the Diagnosis of Gallbladder Cancer. Annals of Surgical Treatment and Research, 101, 266-273. https://doi.org/10.4174/astr.2021.101.5.266
|
[33]
|
张永东. 血清CA199、CA242、CA125联合检测对胆囊癌患者诊断的临床价值研究[J]. 肝胆外科杂志, 2016, 24(2): 106-110.
|